Cost-Effectiveness of Recombinant Human TNK Tissue-Type Plasminogen Activator (Rhtnk-Tpa) Versus Recombinant Tissue Plasminogen Activator (Rt-PA) in Treating STElevation Myocardial Infarction (STEMI)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.